Neuroblastoma is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. In the UK, 100 children are newly diagnosed with neuroblastoma every year. Candlelighters have funded research throughout the last year …
Putting Yorkshire at the forefront of cancer research
Saving more children and their families from the devastating consequences of cancer depends on continuous research.
When Candlelighters was formed in the 1970's, sadly very few of the children survived (just 10%), but today things are different. Research and medicine has advanced so much over the years that now more than 80 per cent of children go on to lead normal, healthy lives.
In addition to our Candlelighters Children's Cancer Research Laboratory in Leeds, we also help fund external research projects across Yorkshire.
The Candlelighters Children's Cancer Research Laboratory opened in 1992, as a result of a huge five year fundraising campaign.
Led by Professor Sue Burchill, the laboratory now enjoys an international reputation, particularly for research into Ewings Sarcoma and Neuroblastoma. It also attracts funding from other research bodies.
In among the research we've helped fund are:
- Neuroblastoma research
- Fertility research projects
- Brain tumour research projects
- Research into symptom prevalence and profiles in childhood cancer and leukaemia
- Development of the Yorkshire Specialist Register of cancer and leukaemia in children and young adults.
- Acute Lymphoblastic Leukaemia projects
Below we will post details of specific research projects Candlelighters have supported so far.
Right now, 2 million people in the United Kingdom are living with or beyond a cancer diagnosis. With this figure set to rise in the future, this study looks at the potential implications and complications for survivors.
Combined with the National Institute for Health Research (NIHR), Cancer Research UK and Leeds Teaching Hospitals NHS Trust, Candlelighters funded research with the purpose of influencing NHS policies and clinical care in paediatric and adolescent medicine.
Over the last 30 years we have been instrumental in the development of the paediatric oncology/haematology research infrastructure in Leeds. Together with other major institutions, Candlelighters is giving talented clinicians the opportunity to learn from world-leading research teams. Ensuring that Leeds continues to lead the way in cancer research.
In 2014 Candlelighters funded Sue Burchill to continue a specific area of research. This work is the result of a decade of dedication and is likely to be used as a tool to stratify patients treatment within the next Neuroblastoma clinical trial.